Sakra World Hospital - Best Multispeciality Hospital in Bangalore India
Home

October 16th, 2017

The Felicitation of Dr. Swaroop Gopal and Dr. Satish Rudrappa at Hokkaido University Graduate School of Medicine, Sapporo, JAPAN

Dr. Swaroop Gopal and Dr. Satish Rudrappa are nominated as visiting professors for the Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, JAPAN.

Dr. Swaroop and Dr. Satish received their award from Professor Kiyohiro Houkin at the award ceremony held at Hokkaido University Hospital on October 16th, 2017.

Nearly 35 doctors attended the Special Lecture of Dr. Swaroop and Dr. Satish. There was also a message from Prof Houkin that Hokkaido University is keen to deepen the clinical relationship with SAKRA World Hospital.

History of The Hokkaido University neurosurgery:

The Hokkaido University neurosurgery program was first formed in January 1958 under the leadership of Dr. Mitsuo Tsuru shortly after his return from neurosurgical training in the United States. At that time, neurosurgery was a sub-group within the Departments of Surgery and Psychiatry. In July 1958, Dr. Tsuru was elected lecturer of the Department of Psychiatry and 18 beds were installed for neurosurgery. Beginning in 1961, the department began to offer a six-year residency program for young neurosurgeons, modeled after the curricula Dr. Tsuru had observed in the United States. This program has since become a trademark of the department. In 1965, Hokkaido University’s Department of Neurosurgery was established as a distinct department, becoming the third national-university-level neurosurgical department.

Hokkaido University Graduate School of Medicine, Chief Professor, Hospital Director, and University Vice President KIYOHIRO HOUKIN

Dr. Houkin is an expert in surgical treatment of cerebrovascular disease, such as cerebral aneurysm, and Moyamoya disease. He also serves as a director of Hokkaido University hospital which requires broad experience and responsibility throughout all medical fields and led him to one of the top leaders in the field of risk and emergency medical management in Japan. As a neuroscientist, he has been engaged in basic research regarding Moyamoya disease and stem cell therapy for ischemic stroke.

Contact Us
scam alert